Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | GLYC |
---|---|---|
09:32 ET | 34546 | 0.265 |
09:34 ET | 7719 | 0.265 |
09:36 ET | 976 | 0.266701 |
09:38 ET | 2833 | 0.266701 |
09:39 ET | 2115 | 0.2693 |
09:41 ET | 7690 | 0.27 |
09:43 ET | 47762 | 0.2815 |
09:45 ET | 21820 | 0.277 |
09:48 ET | 27499 | 0.275 |
09:50 ET | 43799 | 0.2799 |
09:52 ET | 76171 | 0.281 |
09:54 ET | 38075 | 0.2812 |
09:56 ET | 414 | 0.28 |
09:59 ET | 400 | 0.2727 |
10:08 ET | 1200 | 0.273 |
10:10 ET | 200 | 0.2728 |
10:12 ET | 6418 | 0.274801 |
10:15 ET | 290 | 0.2728 |
10:21 ET | 12000 | 0.2727 |
10:24 ET | 1103 | 0.2727 |
10:26 ET | 965 | 0.27 |
10:28 ET | 27400 | 0.268 |
10:30 ET | 5745 | 0.269999 |
10:35 ET | 2282 | 0.2694 |
10:37 ET | 1100 | 0.2701 |
10:39 ET | 1009 | 0.2692 |
10:42 ET | 1100 | 0.2702 |
10:48 ET | 100 | 0.270101 |
10:50 ET | 3419 | 0.2708 |
10:51 ET | 1510 | 0.2705 |
10:53 ET | 553 | 0.27 |
10:57 ET | 100 | 0.27 |
11:02 ET | 100 | 0.27 |
11:04 ET | 1100 | 0.27 |
11:06 ET | 1000 | 0.27 |
11:11 ET | 615 | 0.2701 |
11:15 ET | 2790 | 0.27005 |
11:18 ET | 394 | 0.2701 |
11:20 ET | 1124 | 0.27 |
11:26 ET | 1400 | 0.2701 |
11:27 ET | 14317 | 0.275 |
11:29 ET | 11597 | 0.2741 |
11:31 ET | 2000 | 0.2736 |
11:33 ET | 1395 | 0.2757 |
11:36 ET | 5300 | 0.275 |
11:38 ET | 5935 | 0.2731 |
11:45 ET | 200 | 0.273 |
11:49 ET | 915 | 0.2714 |
11:51 ET | 1813 | 0.27151 |
11:54 ET | 1811 | 0.2712 |
12:03 ET | 1065 | 0.270307 |
12:07 ET | 100 | 0.2702 |
12:12 ET | 100 | 0.2702 |
12:14 ET | 588 | 0.2702 |
12:18 ET | 751 | 0.2713 |
12:20 ET | 1200 | 0.2703 |
12:21 ET | 12418 | 0.2694 |
12:23 ET | 18154 | 0.2674 |
12:25 ET | 2165 | 0.2669 |
12:27 ET | 62096 | 0.2664 |
12:30 ET | 3634 | 0.2672 |
12:32 ET | 2816 | 0.2711 |
12:36 ET | 8200 | 0.2697 |
12:39 ET | 1300 | 0.2672 |
12:41 ET | 1080 | 0.2681 |
12:48 ET | 1702 | 0.2681 |
12:50 ET | 3500 | 0.2672 |
12:56 ET | 4700 | 0.2672 |
12:59 ET | 400 | 0.267201 |
01:01 ET | 14012 | 0.2653 |
01:03 ET | 10923 | 0.2653 |
01:06 ET | 26680 | 0.263 |
01:08 ET | 500 | 0.2663 |
01:10 ET | 100 | 0.264 |
01:12 ET | 1508 | 0.2646 |
01:14 ET | 950 | 0.2658 |
01:15 ET | 8492 | 0.2673 |
01:17 ET | 3162 | 0.265 |
01:19 ET | 2807 | 0.2654 |
01:21 ET | 1800 | 0.2659 |
01:24 ET | 1000 | 0.2657 |
01:28 ET | 2000 | 0.2661 |
01:30 ET | 1511 | 0.2665 |
01:32 ET | 1200 | 0.2672 |
01:33 ET | 2763 | 0.2699 |
01:37 ET | 150 | 0.269999 |
01:39 ET | 1200 | 0.269 |
01:42 ET | 100 | 0.268 |
01:48 ET | 1000 | 0.269 |
01:50 ET | 1000 | 0.2681 |
01:53 ET | 3000 | 0.27 |
01:55 ET | 100 | 0.2699 |
01:57 ET | 105 | 0.2663 |
02:02 ET | 1100 | 0.2668 |
02:04 ET | 300 | 0.2663 |
02:06 ET | 2200 | 0.2668 |
02:08 ET | 200 | 0.2668 |
02:09 ET | 800 | 0.2662 |
02:11 ET | 4110 | 0.2668 |
02:13 ET | 2319 | 0.2668 |
02:18 ET | 3300 | 0.2671 |
02:20 ET | 600 | 0.2673 |
02:22 ET | 300 | 0.267 |
02:26 ET | 24329 | 0.274 |
02:27 ET | 400 | 0.273 |
02:29 ET | 400 | 0.272 |
02:33 ET | 100 | 0.2714 |
02:36 ET | 4909 | 0.27 |
02:38 ET | 600 | 0.2694 |
02:40 ET | 4500 | 0.2668 |
02:42 ET | 4150 | 0.26785 |
02:47 ET | 2912 | 0.2668 |
02:49 ET | 1240 | 0.2672 |
02:56 ET | 2456 | 0.2661 |
02:58 ET | 606 | 0.26655 |
03:00 ET | 8473 | 0.2683 |
03:02 ET | 1675 | 0.2688 |
03:03 ET | 200 | 0.2708 |
03:05 ET | 1500 | 0.2705 |
03:12 ET | 5369 | 0.2699 |
03:14 ET | 3707 | 0.2683 |
03:16 ET | 9805 | 0.2683 |
03:18 ET | 126 | 0.268651 |
03:20 ET | 10248 | 0.2689 |
03:23 ET | 100 | 0.2665 |
03:25 ET | 3700 | 0.2656 |
03:27 ET | 10005 | 0.2656 |
03:30 ET | 500 | 0.2646 |
03:32 ET | 2500 | 0.2657 |
03:34 ET | 23427 | 0.2674 |
03:36 ET | 5913 | 0.2678 |
03:39 ET | 100 | 0.2682 |
03:41 ET | 3739 | 0.2682 |
03:43 ET | 2300 | 0.2671 |
03:45 ET | 1100 | 0.2666 |
03:50 ET | 2488 | 0.2661 |
03:52 ET | 42208 | 0.2666 |
03:54 ET | 7241 | 0.267 |
03:56 ET | 29846 | 0.272 |
03:57 ET | 400 | 0.2676 |
03:59 ET | 5879 | 0.27 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
GlycoMimetics Inc | 17.4M | -0.5x | --- |
Curative Biotechnology Inc | 17.4M | -1.8x | --- |
CytoMed Therapeutics Ltd | 23.9M | -7.1x | --- |
Minerva Neurosciences Inc | 17.1M | -0.5x | --- |
Galecto Inc | 17.1M | -0.5x | --- |
Aptose Biosciences Inc | 18.1M | -0.2x | --- |
GlycoMimetics, Inc. is a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers, including acute myeloid leukemia (AML) and for inflammatory diseases. It is developing a pipeline of glycomimetics, which are small molecules that mimic the structure of carbohydrates involved in biological processes, to inhibit disease-related functions of carbohydrates, such as the roles they play in inflammation, cancer and infection. Its drug candidates include Uproleselan, GMI-1687, Galectin Antagonists and GMI-1359. It is developing Uproleselan, a specific E-selectin antagonist, to be used in combination with chemotherapy to treat patients with AML, a life-threatening hematologic cancer, and potentially other hematologic cancers. It has designed an antagonist of E-selectin, GMI-1687, that is suitable for subcutaneous administration. GMI-1359 is a drug candidate that simultaneously targets both E-selectin and a chemokine receptor (CXCR4).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $17.4M |
---|---|
Revenue (TTM) | $10.0K |
Shares Outstanding | 64.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.11 |
EPS | $-0.58 |
Book Value | $0.60 |
P/E Ratio | -0.5x |
Price/Sales (TTM) | 1,740.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -394,493.10% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.